What is Bryn Pharma worth?
$225.0Mlast known valuation
Bryn Pharma last raised $26.7M in its Early Stage VC (Apr 2023).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·Watchlist + deal alerts for Bryn Pharma
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2023 | Early Stage VC | $26.7M | ▮ | ▮ |
| Jul 2021 | Early Stage VC | $43.5M | ▮ | ▮ |
| Oct 2019 | Early Stage VC | $26.0M | ▮ | ▮ |
| Feb 2019 | Early Stage VC | $17.2M | ▮ | ▮ |
How Bryn Pharma's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Bryn Pharma, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Bryn Pharma worth?
- Bryn Pharma's last known valuation is $225.0M.
- How much has Bryn Pharma raised?
- Bryn Pharma has raised $127.4M in total funding across 4 recorded rounds.
- When did Bryn Pharma last raise?
- Bryn Pharma last raised in Apr 2023 (Early Stage VC), raising $26.7M.